Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry J Allen

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Critical Reviews in Oncology/Hematology|February 28, 2018
Global comparison of targeted alpha vs targeted beta therapy for cancer: In vitro, in vivo and clinical trialsLoredana Marcu, Eva Bezak, Barry J Allen
Melanoma Management|September 8, 2018
The potential complementary role of targeted alpha therapy in the management of metastatic melanomaMichael P Brown, Eva Bezak, Barry J Allen
Biomed Research International|July 18, 2013
Quo vadis radiotherapy? Technological advances and the rising problems in cancer managementBarry J Allen, Eva Bezak, Loredana G Marcu
Expert Review of Anticancer Therapy|May 27, 2004
Targeted alpha-therapy for control of micrometastatic prostate cancerYong Li, Pamela J Russell, Barry J Allen
Medical Physics|July 3, 2015
POINT/COUNTERPOINT: Systemic α-particles are likely to yield more important advances in radiotherapy than are protonsBarry J Allen, Alexei V Chvetsov, Colin G Orton
Cancer Treatment Reviews|January 10, 2012
Optimizing radioimmunoconjugate delivery in the treatment of solid tumorChen-Yu Huang, Mohammad H Pourgholami, Barry J Allen
Biologics : Targets & Therapy|November 26, 2014
Targeted alpha anticancer therapies: update and future prospectsBarry J Allen, Chen-Yu Huang, Raymond A Clarke
Medical Physics|March 3, 2012
Monte Carlo calculation of the maximum therapeutic gain of tumor antivascular alpha therapyChen-Yu Huang, Bradley M Oborn, Susanna Guatelli, et al.
Computational and Mathematical Methods in Medicine|September 19, 2012
Microdosimetry for targeted alpha therapy of cancerChen-Yu Huang, Susanna Guatelli, Bradley M Oborn, et al.
Physics in Medicine and Biology|August 1, 2007
Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancerBarry J Allen, Chand Raja, Syed Rizvi, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Critical Reviews in Oncology/Hematology|February 28, 2018
Global comparison of targeted alpha vs targeted beta therapy for cancer: In vitro, in vivo and clinical trialsLoredana Marcu, Eva Bezak, Barry J Allen
Melanoma Management|September 8, 2018
The potential complementary role of targeted alpha therapy in the management of metastatic melanomaMichael P Brown, Eva Bezak, Barry J Allen
Biomed Research International|July 18, 2013
Quo vadis radiotherapy? Technological advances and the rising problems in cancer managementBarry J Allen, Eva Bezak, Loredana G Marcu
Expert Review of Anticancer Therapy|May 27, 2004
Targeted alpha-therapy for control of micrometastatic prostate cancerYong Li, Pamela J Russell, Barry J Allen
Medical Physics|July 3, 2015
POINT/COUNTERPOINT: Systemic α-particles are likely to yield more important advances in radiotherapy than are protonsBarry J Allen, Alexei V Chvetsov, Colin G Orton
Cancer Treatment Reviews|January 10, 2012
Optimizing radioimmunoconjugate delivery in the treatment of solid tumorChen-Yu Huang, Mohammad H Pourgholami, Barry J Allen
Biologics : Targets & Therapy|November 26, 2014
Targeted alpha anticancer therapies: update and future prospectsBarry J Allen, Chen-Yu Huang, Raymond A Clarke
Medical Physics|March 3, 2012
Monte Carlo calculation of the maximum therapeutic gain of tumor antivascular alpha therapyChen-Yu Huang, Bradley M Oborn, Susanna Guatelli, et al.
Computational and Mathematical Methods in Medicine|September 19, 2012
Microdosimetry for targeted alpha therapy of cancerChen-Yu Huang, Susanna Guatelli, Bradley M Oborn, et al.
Physics in Medicine and Biology|August 1, 2007
Tumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancerBarry J Allen, Chand Raja, Syed Rizvi, et al.
Pageof 6